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A COMPARATIVE STUDY OF SOME OF THE ASPECTS INVOLVED IN 
THE REGULATION OF GLYCOLYSIS IN HUMAN DIPLOID 
AND VIRAL TRANSFORMED CELLS
CHAPTER I 
INTRODUCTION AND LITERATURE SURVEY
The transformation of cells by oncogenic viruses 
probably offers the best "in vitro" opportunity for de­
termining the early events of neoplastic conversion. Cells 
may be transformed by ribonucleic acid (RNA) and deoxy­
ribonucleic acid (DNA) containing viruses, and the character 
of the transformation is dependent upon the type of inter­
action that these viruses make with the cells which they 
transform. The RNA containing viruses that can effect viral 
transformation-are the murine leukemic and avian leukosis 
groups, and the DNA containing viruses capable of Inducing 
cell transformation are polyoma virus, the vacuolating 
simian virus (SV̂ -0) and certain adenoviruses. RNA viral 
transformation may be subdivided into two groups based on 
the formation of infectious virus. In the murine leukemic 
and certain avian leukosis groups, the virus continues to 
be produced by the tumor and released into the medium by
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buddingo In the Rous sarcoma viral transformed cell, very 
little, if any, infective virus is found. Transformation of 
cells by DNA oncogenic viruses results in no detectable 
viruses in cell extracts. The DNA and Rous sarcoma viral 
transformations differ in that for the DNA viral transformed 
cells viruses can only be induced in exceptional cases, and 
for Rous sarcoma viral transformed cells infectious virus 
can be readily obtained under the proper conditions. For 
example, when the Bryan high titer strain of Rous sarcoma 
virus is used to transform chicken cells, superinfection 
with a helper virus of the avian leukosis group leads to 
formation of infectious viruses. The helper virus promotes 
infection by synthesizing the protein coat that can not be 
produced by the Rous sarcoma virus. Interaction of the 
Schmidt-Rubin strain of Rous sarcoma virus with mammalian 
cells leads to transformed mammalian cells which do not 
release virus until the cells are cultured with chick 
embryo cells (2'+).
Since the transformed cells used in this research 
project were transformed by SVH-0, it is pertinent to con­
sider the literature in some detail on viral transformation 
by SV̂ -0. Infection of new born hamsters with SYhO re­
sulted in the formation of malignant tumors at the injection 
site (20, 2 3). The discovery of this oncogenic agent 
prompted a study on the behavior of human tissue exposed to 
infection with 8V40. Biopsies of buccal mucosa and skin
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from adult male and female humans were cultured and infected 
with SV̂ -0 (3^)0 Initially no morphologic differences were 
observed in either the infected or noninfected cells, and 
both cell types readily formed monolayers. Between eight 
and fourteen weeks the first visible indication of a change 
in the infected and virus yielding cultures was the ap­
pearance of areas of tightly packed and linearly arranged 
cells. Numerous cells exhibited perinuclear granulation and 
were in mitosis. Further passages of these cells resulted in 
increasing numbers of colonies of the transformed cells with 
the non-transformed cells finally disappearing. The trans­
formed cells exhibited an epithelial-like morphology in 
contrast to a fibroblast-like morphology for non-transformed 
cells. In addition, transformed cells were irregular, poly­
morphic, and had large nucleoli. If both cell types were 
provided equal surface areas on which to form confluent 
sheets, approximately two-fold to three-fold more cells were 
found in the cultures of the transformed cells which indi­
cates either smaller cells, tighter packing, or multi­
layers of cells. Also, considerably more mitotic activity 
occurred in the transformed cells, and the transformed 
cells were found to have a greater growth rate than non­
transformed cells. The viral transformed cells were also 
found to have an abnormal karyotype, but the non-transformed 
cells were karyotypically normal. Continued passage of the 
transformed cells has indicated that the transformation did
not produce reversible phenotypes which was suspected since 
chromosomal aberrations accompany the transformation (3^)» 
Since earlier work on SV -̂0 transformation was done 
with an organ culture that originally contained epithelial 
cells, transformations of a pure strain of human fibroblasts 
were necessary to prove whether the fibroblasts were a re­
sult of selection of the original organ fibroblasts or of 
viral transformation. The following work was initiated to 
clarify this problem (*+). It was found in contrast to organ 
cultures that in cell cultures the morphological transforma­
tion of fibroblasts to epithelioid cells was gradual. This 
transformation was characterized by formation of an undif­
ferentiated rapidly dividing, aneuploid population that was 
well adapted to "in vitro" cultivation. Examination of the 
nucleoli indicated an excess of DNA around it and it was 
speculated (4^) that disturbance of the nucleolus may play 
an important role in the SV40 transformation. Some of the 
transformed cell lines were found to have ceased viral 
shedding, but they were exceptions. The SV40 antigen present 
in a small fraction of the transformed cells was always 
shown by immunofluorescence to be present in the nucleolus. 
The conclusion from this work was that the fibroblasts were 
formed as a result of viral transformation. Later work on 
SV4o transformation of human diploid cells revealed the 
characteristic features of the phases of crises and recovery 
of SV4o induced transformation (22). These authors found.
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as was previously reported, that SV̂ -0 transformed cells 
underwent morphological change, accelerated growth rate, and 
an extended survival beyond the life span characteristic of 
human diploid cells in culture. However, extended observa­
tion indicated that four to eight months after transforma­
tion, the ability to proliferate declined and the transformed 
cells displayed abnormal mitosis. The period of time that 
the cells indicated minimal survival was defined as 
’’crisis." Following the "crisis" a new type of cell emerged 
which could be easily subcultured. If the transformed cells 
were assayed for infectious SV̂ -0 periodically before and 
during crisis, some virus was always detected, but after 
recovery no virus could be detected. Also, a new cellular 
protein was revealed by complement-fixation. This SV̂ -0 in­
duced complement-fixing antigen distinct from the viral 
antigen was found in high titer after recovery as well as 
before crisis. Presence of this antigen in subsequent 
progeny indicated that it was an inheritable trait and may 
indicate either integration of viral genetic material or 
derepression of genetic material in the host cell, A more 
complete discussion of this antigen will be presented after 
the following discussion on the evidence for the presence of 
the viral genome persisting in the viral transformed cell.
Hybridization experiments with DNA from 8V40 trans­
formed hamster cells (SV3T3 ) and labeled virus specific RNA 
were performed on membrane filters by the Gillespie-
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Spiegelman procedure (6 3). It was hoped that enough of the 
viral genome would he present in the transformed cells' DNA 
to hybridize with virus specific RNA. The virus specific 
RNA was made using viral DNA as a template with Escherichia 
coli RNA polymerase. The results of the experiments indi­
cated about five, to twenty 8V40 DNA molecules per cell. The 
second project of this study involved the fusion of SV3T3 
cells with BSC-1 cells which was accomplished using ultra­
violet irradiated Sendai virus as the fusing agent.
Although the SV3T3 cells do not produce virus about ten 
percent of the fused cells produced infectious SV̂ -0. These 
results indicated that integration of the viral genome was 
reversible and that complete viral genomes could be inte­
grated into the SV3T3 cells (6 3). A similar study by 
Dulbecco's-group compared the viral RNA synthesized in BSC-1 
cells lytically infected with SV4-0 with RNA synthesized in 
SV3T3 cells (5 7)* In the transformed cells it'was found 
that one-third of the viral DNA was expressed as RNA, and 
the transcribed genes overlapped mostly with the S'V̂ -O genes 
active during early lytic infection. These findings were 
indicative that, at the most, one-third of the total viral 
genome was essential for transformation which corresponded 
roughly to two or three genes. These findings also strongly 
suggested that the late functions in the S'V40 lytic cycle 
were irrelevant for transformation (57)*
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Recently, it has been reported that human diploid 
cells could be transformed by DNA extracted from 8V4-0. The 
absorption of the DNA was mediated by incubation of the 
human cells and SVU-0 DNA with diethylaminoethyl dextran.
The transformed cells produced SV^O T-antigen, were 
epitheloid, showed loss of contact inhibition of cell di­
vision and readily formed multiple cell layers. Persistent 
nuclear abnormalities and giant cells were also found (1).
As was discussed earlier specific antigens are 
demonstrable in virus induced tumors and cells transformed 
"in vitro" by viruses. These antigens may be divided into 
two categories, viral and cellular antigens. Viral antigens 
consist of structural proteins which are part of the intact 
virus. Cellular antigens are induced in the cell as a result 
of transformation but are not incorporated into the mature 
virus. In cells transformed by DNA viruses only cellular 
antigens are observed; however, in cells transformed by RNA 
viruses both cellular and viral antigens are found (24J.
The cellular antigens belong to one of two general sub­
categories based on the immunological technique used for 
detection of the antigen. They are the transplantation 
type and serological type antigens. The transplanatation 
type antigen refers to the antigenically different cell 
surface that elicits an immunological reaction by the host 
animal to its own virus induced tumor. The serological type 
antigens are determined by serological techniques and are
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postulated to be the early virus-induced enzymes involved in 
DNA synthesis since these antigens appear at the same, time 
as the increase in certain enzymes involved in virus- 
induced cellular DNA synthesis. The appearance of specific 
antigens in transformed cells is now accepted as a general 
phenomenon, and although not directly shown, it is likely 
that their biosynthesis is coded by a persisting viral 
genome or at least a part of the viral genome. An interest­
ing feature of these antigens is that their specificity is 
dependent on the original inducing virus and that they are 
present in all viral induced tumors regardless of the 
species of the host (2U-).
Next it is of interest to consider the character­
istics of the human diploid cell strains. In 1961 Hayflick 
and Moorhead coauthored a paper that described certain cri­
teria for the serial cultivation of human diploid cell 
strains (26). Up to that time only limited success had been 
obtained in cultivating human diploid cells "in vitro" over 
long periods of time. Since diploid cells parallel more 
closely the "in vivo" karyotype, their development would 
offer cell strains that should parallel more closely the 
"in vivo" biology of cells. Their paper also- stresses the 
need for clarification of terminology used in tissue culture. 
The term cell strain defines a population of cells derived 
from animal tissue which has been cultivated more than once 
"in vitro," has a defined life span, and maintains one
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diploid karyotype characteristic of the source tissue 
throughout its "in vitro" life span. Conversely, a cell 
line is a population of cells derived from animal tissue and 
grown "in vitro" by serial subcultivations for indefinite 
periods of time with a departure from the chromosome number 
characterizing its source. The term orimarv cells should 
indicate those cells obtained from the original source that 
have been cultivated "in vitro" for the first time. Thus 
the properties that primary cells assume after subsequent 
passages determine whether the cells are defined as a cell 
strain or as a cell line. These authors report successful 
cultivation of 25 human diploid cell strains from lung, 
muscle, skin, kidney, thymus, and heart. All the cells 
maintained a diploid karyotype and fibroblastic morphology 
throughout a finite "in vitro" life span. In general, the 
nucleus contains one to four nucleoli which vary from oval 
to branched bodies, and multinucleated cells are rarely 
found. The cells are transparent with fine cytoplasmic 
granularity, and the cell membrane is filamentous. "In 
vitro" these fibroblasts are extremely elongated, averaging 
about 185 microns by 15 microns. The confluent sheet is 
composed of swirls of cells with each cell aligned in a 
common direction. Gradually with continued transfers the 
•cells change from an active mitotic state to a less active 
mitotic state and begin to accumulate debris. Also, the 
cells display less differences in the length of'the axes and
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lose contact inhibition. Various attempts to recover the 
cells e.g. medium changes or subcultivations always fail.
From these observations it is evident that the life history 
of a cell strain may be characterized by three distinct 
phases. Phase I, or the early growth phase, denotes that 
period of time when the primary cells are introduced to 
tissue culture until the first confluent sheet is formed. 
Phase II is characterized by rapid cell multiplication and 
acid production. Phase III or the terminal phase is char­
acterized by the appearance of debris and reduced mitotic 
activity which is manifested in tissue culture by longer 
periods of time required for confluency. A large majority 
of Phase III cells remain diploid, but bizarre nuclear forms 
and sizes are frequently observed (26).
The previous discussion of human diploid cells and 
their 8V40 Viral transformation has been of a general nature, 
and applies only generally to the cells used for this re­
search project. Thus, a discussion concerning the cells 
used in this research is pertinent. The cells which were 
chosen for this research project were the human diploid 
cell strain Wl -38 and its SYhO transformed counterpart 
Wl-3 8 VA13A. Wl -38 was originally cultured by Hayflick from 
human male embryonic lung tissue. Wl -38 has the general 
characteristics of human diploid cells. They maintain 
diploidity throughout their life span and exhibit fibroblast­
like morphology. Also, they exhibit the Phase III
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phenomenon, hut their "in vitro" life span is of sufficient 
length to permit them to he a practical research tool. In 
fact ¥1-38 is sold as a commercial cell strain hy many 
tissue culture companies.
Infection of Wl-3 8 with SV^O transforms it to a cell 
type that originally produces infectious SV̂ -0; however, in 
approximately five months the crisis stage results in a 
drastic drop in cell number. The cell line, Wl-38 VAI3A, 
was originated from the cells which survived the crisis 
period. These transformed cells are heteroploid and exhibit 
an epithelial-like morphology. Also the transformed cells 
have the antigenic properties characteristic of cells trans­
formed hy DNA viruses. It was noted independently hy two 
research groups that for Phase III cells a shorter time 
elapsed between infection and transformation than for 
Phase II cells (31, 5^)* The reason for this enhanced trans­
formation has not been established, but it could be due to 
an increased efficiency of adsorption and penetration by 
the virus.
Previous work has shown that Wl-38 glycolysis pro­
ceeded at a uniform rate which was directly dependent on 
cell division and respiration rate (16, 37)* Even though 
Wl -38 cells exhibit lower mitotic activity while in Phase 
III, their total respiration, glucose respiration, and 
glycolytic capacity was not significantly altered from 
that observed for Phase II cells. Also, the predominate
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fate of glucose remained lactic acid production (I7 ). In 
perfusion systems there were trends which indicate that 
Wl -38 VA13A. Since the data were scattered, it was not pos­
sible to state whether the two cell types were statistically 
different (3 6).
Glucose metabolism has been studied for other virus 
transformed cells. Glucose metabolism has been studied in 
Rous sarcoma tumors grown in chickens (40. The following 
conclusions could be made concerning the overall metabolism 
of the Rous sarcoma tumor: (1) Glucose was readily utilized
and its rate of utilization was increased with increasing 
concentrations of glucose, and (2) the hexose monophosphate 
shunt was operative, but the' maximum contribution of this 
route did not exceed four percent of the glucose used» Be­
tween 15 to 20 percent of the consumed labeled pyruvate 
could be accounted for as carbon dioxide, and no significant 
incorporation of labeled carbon from pyruvate was observed 
in the tissue glycogen (4). A comparative study of the glu­
cose metabolism in BHK21 cells and Rous sarcoma virus trans­
formed BHK21 cells indicated that the transformed cells have 
a two fold greater glucose consumption than the non­
transformed cells (9 ). In more recent work it was found 
that cells transformed by Rous sarcoma viruses had the same 
over-all glycolytic capacity as uninfected chick embryo 
cells. However, the viral transformation conferred on the 
cells a greater potential for growth and glycolysis under
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conditions that limited the growth of untransformed BHK21 
cells e.g. serum depletion, growth in suspension culture and 
thymidine blockage (52).
Several enzymatic studies have been made which com­
pared the enzymatic activity of transformed cells with non­
transformed cells. Weber and coworkers compared several 
enzyme activities of 10 to 16 day chorio-allantoic membranes 
with Rous sarcoma transformed membrane (58). fhey found no 
significant differences in the specific activities (measured 
in micromoles of substrate utilized per hour per average
Q
cell x10 ) for fructose diphosphatase, glucose-6-phosphate 
dehydrogenase, and 6-phosphogluconate dehydrogenase. How­
ever, for the viral induced tumor they found approximately 
four fold increases in phosphoglucomutase and lactate de­
hydrogenase specific activities as well as a two fold in­
crease in the specific activity of phosphoglucoisomerase. 
Using BHK21 cells and polyoma virus transformed BHK21 cells, 
there was consistently higher aerobic and anaerobic glycol­
ysis in the transformed cells. Enzymatic comparisons of 
these two cell types indicated higher hexokinase, NADP^ 
specific-isocitrate dehydrogenase, and malic dehydrogenase 
activities in the transformed cells, but lower G6PDH activ­
ity in the transformed cell (46). Cristofalo and coworkers 
have demonstrated that alkaline phosphatase activity is 
about three fold higher in Wl -3 8 VAI3A when compared to 
Wl-3 8 , while the activities of acid phosphatase and lactate
1^
dehydrogenase are not statistically different in both cell 
types (I5j 1 8). More recently he has reported that hexo­
kinase is the rate limiting enzyme for glucose utilization 
in both cell types, and of the glycolytic enzymes only 
glucose phosphate isomerase was significantly different 
(approximately two fold higher in Wl -38 VA13A). Also, 
6 -phosphogluconate dehydrogenase and transaldolase activ­




From the reviewed literature it is evident that the 
biology of virus induced cells as well as their gross 
glycolytic and respiration rate has been partly studied. 
However, relatively few studies have been made correlating 
any observed differences in glycolysis with intercellular 
differences between the transformed and untransformed cells.
The goal of this research is to make a comparative 
study of the glycolytic capacities of human diploid and SV̂ -0 
viral transformed cells and to explain any variation in 
glycolysis on the basis of enzyme profiles and/or response 
of certain enzymes to substrate and some regulatory ef­
fectors which are thought to control cellular glycolysis.
It is hoped that the results of this research may be useful 




EXPERIMENTAL MATERIALS AND METHODS
The original starter cultures of Wl-38 and Wl-38  
VA13A were obtained from Dr. Paul F. Kruse, Jr. and 
Dr. V. J. Cristofalo, respectively. Both cell types were 
cultured in basal medium (Eagle), BME, containing Earle's 
salts, 10^ calf serum, 100 units of penicillin per ml of 
medium and 100 meg of streptomycin per ml of medium. One 
liter of medium was prepared by adding 100 ml of 10 X BME 
with Earle's salts, 20 ml of a solution containing 5?000 meg 
of streptomycin and 5?000 units of penicillin per ml,
100 ml of calf serum, and 50 ml of a sterile solution 
(sterilized with a MLllipore stainless steel pressure filter 
holder using compressed nitrogen at a pressure head of 
5 pSi) of (w/v) sodium bicarbonate to 730 ml of water.
The water was double distilled in a glass still and ster­
ilized for )+5 minutes by double autoclaving at a 24- hour 
interval. All 10 X BME, antibiotics, and calf serum were 
purchased from Grand Island Biological Company.
Both cell types were grown in two liter Povitsky 
flasks with 150 ml of complete medium. The bottles were
16
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gassed through tightly cotton packed 25 ml pipettes for 
30 seconds with a 5^ COg in air mixture and then stoppered 
with silicone stoppers (West and Company). Prior to use, the 
Povitsky flasks were soaked in soap (Linhro Chemical 
Company) for at least one week and then vigorously rinsed 
with tap water, followed by a rinse with double glass dis­
tilled water. When the pH of the medium fell to about 
seven, the medium was changed and the flask restoppered 
without gassing. After the pH of the second feeding dropped 
to about seven, the medium was removed; and the cells were 
ready to be harvested.
The cell sheet was harvested from the glass surface 
by treatment with an 0.05^ (w/v) pronase solution. The 
pronase was purchased from Calbiochem. The pronase solution 
was prepared by adding 50 mg of pronase per 100 ml of Earle's 
salt solution minus glucose and was sterilized by filtra­
tion through a candle type sterilizing filter. To each two 
liter Povitsky flask, 10 ml of sterile pronase solution was 
added. The pronase was left in contact with the cell sheet 
until the cell sheet began to form a mosaic-like pattern, and 
then the pronase solution was rapidly decanted before the 
cell sheet could break loose from the surface on which it 
was growing. After removing the pronase the flask was 
agitated by rocking until the cell sheet was completely free 
from the surface. Then 10 ml of medium was added to the 
cells and was aspirated vigorously at least ten times to
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break up cell clumps. This was accomplished with a sterile 
cotton plugged 10 ml plastic pipette (Falcon Plastics). For 
¥1 -38 all but 3 ml of the aspirated cell-medium solution was 
removed and added to a sterile centrifuge tube and for 
¥1 -3 8 VA13A all but one ml of cells and medium was removed 
and also added to a sterile centrifuge tube. The cells were 
centrifuged at 2500 rpm for 15 minutes and the pellet was 
used in various assays. To the cells remaining in the 
Povitsky flask 150 ml of medium was added, and the flask was 
gassed for 30 seconds with a 5% COg in air mixture and 
stoppered with a silicone stopper. All harvesting and 
transfers were performed in a laminar flow clean working 
station (Agnew-Higgins,. Inc.) and all glassware was washed 
in 7X soap before use.
For the glucose and lactate determinations the spent 
medium was removed and immediately deproteinated with an 
equal volume of 0.6M perchloric acid. The original inoculum 
of cells and the final number of cells were determined by 
diluting the cells to 300 to 400 cells per hemacytometer 
chamber with fresh medium and counting in duplicate.
Usually, the proper dilution for the hemocytometer when using 
two liter Povitsky flasks is 1 to 5 for ¥1 -3 8 and 1 to 10 
for ¥1-38 VA13A. The concentration of glucose was de­
termined by using a Sigma glucose determination kit. The 
instructions suggest that the blank contain 0 .1 ml of color 
reagent (2 . 5  mg o-dianisidine dihydrochloride per ml).
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6.0 ml enzyme solution which contains buffered glucose 
oxidase and peroxidase, and 0.2 ml of distilled water. Each 
assay on the spent medium was prepared as the blank except 
that 0.2 ml of deproteinized medium was substituted for the 
0.2 ml of distilled water. The assays were made in tripli­
cate with one blank. After the assay mixtures have incu­
bated at 37°C for two hours, the change in absorbance was 
measured against the blank at 500 nm. The absorbance value 
was converted to concentration of glucose in the de­
proteinated medium in mg/ml by dividing it by 0.84-. The 0.8*+ 
value is determined from a standard curve which was prepared 
by diluting the stock medium, which contains one mg of 
glucose per ml, with an Earle's salt solution to obtain the 
desired glucose concentration. Then each glucose solution 
was deproteinated with an equal volume of 0.6 M perchloric 
acid, centrifuged, and assayed as previously described. The 
mg of glucose consumed was calculated by subtracting the mg 
of glucose per ml in the spent medium from 1 mg per ml which 
is the original concentration of glucose in the fresh 
medium. After the mg of glucose consumed was determined, 
it was converted to micromicromoles per hour per cell change. 
For the determination of lactate a spectrophotometric pro­
cedure from a Calbiochem Biochemica Test Combination in­
struction sheet (art, no. 15 972) was adapted to a 3 ml 
assay. The blank contained 2.5 ml of a 0.50 M glycine 
buffer which was made 0.*+0 M in hydrazine sulfate (Eastman
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Kodak) and buffered to pH 9*0 by adjustment with sodium 
hydroxide; 0 . 2  ml of 0 .0 2 7 M diphosphopyridinenucleotide; 
0 . 2  ml of a lactic acid dehydrogenase solution (1 mg, 
protein/ml); and 0 .1 ml of the deproteinized fresh medium. 
The hydrazine in the buffer reacted with the pyruvate that 
was formed in order to prevent the reverse of the enzymic 
reaction. The assays were prepared in the same way as the 
blank except 0 .1 ml of spent medium was substituted for 
0.1 ml of the fresh medium. The assays were performed in 
triplicate with one blank. After thirty minutes of time at 
3 7°C the absorbance of each assay was measured against the 
blank at 366 nm. Multiplication of the absorbance average 
by 1 .9 converted it to mg of lactate produced per ml which 
was then converted to micromicromoles per hour per cell 
change. The standard curve was obtained by adding lactate 
to the medium and by deproteinizing the solution with an 
equal volume of 0.6 M perchloric acid before assaying.
For the preparation of a cell-free extract for the 
adenylate assays, the cell sheet was loosened by pronase 
treatment as previously described. To the free cell sheet 
10 ml of medium was added per Povitsky flask, and the solu­
tion was aspirated at least ten times. Then an appropriate 
quantity of aspirated solution was transferred to a 25 ml 
graduated cylinder, and the solution was titered with fresh 
medium to a volume that was readily divisible by three. An 
aliquot of cells was removed, diluted to 3OO to k-00 cells
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per hemocytometer, and counted in duplicate. The medium­
cell suspension was dispensed while thoroughly dispersed so 
that one centrifuge tube contained two-thirds of the cells 
and the other centrifuge tube contained one-third of the 
cells, and both cell solutions were centrifuged at 3,000 rpm 
for 15 minutes. The pellet which contained two-thirds of the 
cells was suspended in 50 ml of 0.16 M succinate buffer 
which had been adjusted to a pH of 6.1 with sodium hydroxide. 
The other pellet containing one-third of the cells was 
suspended in 25 ml of 0.10 M tris - HCl buffer at pH 7 .5.
Both buffers were preheated to 60°C before adding to the 
cells in order to denature any enzymes that might alter the 
levels of adenine nucleotides after the cells had been 
broken. While the cells were maintained at 60°C, they were 
sonicated at least 120 seconds at maximum cavitation. The 
temperature of the buffers was held at 60°C for a total of 
four minutes, and then the sonicate was cooled rapidly to 
0°C by transferring to a precooled centrifuge tube (-20°C) 
and by swirling the tube containing the sonicate in a salt- 
ice-water bath. The cooled sonicate was centrifuged at
1 5 ,0 0 0  rpm for 20 minutes at 0°C, and the appropriate quantity 
of the supernatant was used for estimating the levels of 
adenylates in each cell type. The sonicates that were pre­
pared in the succinate buffer were used to determine 
adenosine monophosphate (AMP) and adenosine diphosphate
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(ADP) levels, and the sonicate prepared in the tris buffer 
was used to determine adenosine triphosphate (ATP) levels.
The procedures used to determine AMP and ADP were 
adopted from Kalckar's procedures (33)« For AMP determina­
tion the blank contained 1.0 ml of the succinate buffer and
2.0 ml of assay solution which was the supernatant of the 
centrifuged sonicate. Assays were run in triplicate and 
contained 1.0 ml of 5'-adenylic acid deaminase solution 
(0.08 micromolar units per ml of succinate buffer) and 2.0 ml 
of assay solution. Since the absorption of the assay 
solution was significantly greater than a correction blank 
containing 2.0 ml succinate buffer and 1.0 ml of assay 
enzyme, the AMP was determined directly from the difference 
in absorption of the blank and assay. The difference in 
absorbance was read at 265 nm after 45 minutes incubation 
at room temperature, and it was multiplied by 0.294 to give
the concentration of AMP in the assay solution in micromoles
per ml. Measurement of ADP was performed in an analogous
manner. The blank that was used in the ADP determinations
was identical to the blank prepared for the AMP determina­
tion. As in the AMP determination a correction blank con­
taining the assay enzymes was not necessary. The ADP level 
was measured in a three ml assay containing 0.16 micromolar 
units of 5'-adenylic acid deaminase, and 10 micromolar units 
of myokinase in 1.0 ml of succinate buffer and 2.0 ml of 
assay solution. The difference in absorbance was read at
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265.nm after 60 minutes incubation at room temperature.
Since the ADP assay measured both the AMP present in the 
solution and the AMP produced via the myokinase catalyzed 
reaction, the absorption of the ADP assay must be corrected 
for endogenous AMP by subtracting the absorbance of the AMP 
assay from the total absorption of the ADP assay. Thus the 
difference in the absorbance between the ADP and AMP assays 
is multiplied by 0.130 to obtain the concentration of ADP in 
micromoles per ml of assay solution. The empirical factor 
0 .1 3 0 was obtained from a standard curve.
The procedure used to determine the ATP levels was 
adapted from the method developed by Kornberg (35)* The 
blank contained 1.0 ml of 0.10 M tris-HCl buffer at a pH of 
7 . 5  and 2.0 ml of the tris assay solution. However, in con­
trast to the AMP and ADP assays a correction blank must be 
used for the ATP determination. The correction blank con­
tained 2.0 ml of tris buffer ; 0.2 of a .15 M glucose solu­
tion; 0.2 ml of a 15 mM MgCl2 solution; 0.2 ml of a 1.5 mM 
triphosphopyridine nucleotide solution; 0.2 ml of a hexo- 
kinase solution containing 9 U. per ml of tris; and 0.2 ml 
of a glucose-6- phosphate dehydrogenase solution (0.06 mg 
protein per ml). The assay differed from the correction 
blank in that 2.0 ml of tris assay solution replaced the
2.0 ml of tris buffer. Since the absorbance measured for the 
ATP assay was not an equilibrium value, the absorbance must 
be read after 20 minutes incubation and no later than
2h
25 minutes incubation time. Thus the change in absorbance 
was read as rapidly as possible after 20 minutes at 3^0 nm 
for both the assay and the correction blank. By subtracting 
the absorbance of the correction blank from the absorbance 
of the assay, a corrected absorbance was obtained. By 
multiplying the corrected absorbance by 0.326 the jomoles of 
ATP per ml of tris assay solution was obtained. The standard 
curve was prepared by incubating the ATP standards for 20 
minutes only and the factor 0.326 was determined from this 
curve. All adenine nucleotide levels were converted to 
millimicromoles per 10^ cells for tabulation. All assay 
enzymes, substrates, and cofactors were purchased from Sigma 
Chemical Company unless otherwise specified.
For determination of the enzyme patterns in ¥1-38 
and ¥1-38 VAI3A it was found that the procedures outlined 
by Shonk and Boxer for human tissues were readily adaptable 
to the determination of enzyme patterns in human tissue grown 
"in vitro" (50). The basic methodology that they used for 
the determination of the glycolytic enzymes depends on the 
coupling of the enzyme whose rate was to be measured to the 
oxidation and reduction of the pyridine nucleotides. The 
rate of appearance of product was equated to rate of ap­
pearance or disappearance of reduced pyridine nucleotides 
directly or indirectly by coupled assays. By converting the 
change in absorbance to change in micromoles of reduced 
pyridine nucleotide, the micromoles of product formed is
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estimated. It was found that by multiplying the change in 
absorbance at 3̂ +0 nm by 0.^82 that the micromoles of reduced 
pyridine nucleotide consumed or formed in a 3 ml assay using 
1 cm curvettes can be calculated, and this was equated 
directly with the micromoles of product formed by the enzyme 
whose activity was to be measured (2 7).
For the enzyme pattern studies the cells were pel­
leted as described in the second and third paragraphs of this 
chapter. The cell pellet was suspended in 5 ml of precooled 
extraction medium by aspiration and transferred to a pre­
cooled sonication tube. The extraction medium which was pre­
pared in glass double distilled water contained potassium 
chloride, 0 .15 ?̂ potassium bicarbonate, 0 .05M; and disodium 
ethylenediaminotetracetic acid, 0.006M. The cells were 
sonicated two minutes at maximum cavitation using a probe 
that had been precooled to -20°C. When the sonication tube 
began to feel warm to the touch, it was immersed in a salt- 
ice-water bath to rapidly cool the surface of the tube. The 
sonicate was transferred to a Walgene centrifuge tube that 
had been precooled to -20°C, and then the tube was immersed 
into a salt-ice-water bath and agitated until the temperature 
of the sonicate was about 0°C. The precooled sonicate was 
centrifuged at 15,000 rpm for 30 minutes in a Sorval RC-2B 
centrifuge with a SS-3^ head at 0°C. The supernatant was 
used directly to assay the desired enzymes and immediately 
for determination of enzyme patterns.
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Each enzyme was measured in tris buffer (0.05 M) at 
pH 7 . 6  containing disodium ethylenediaminotetracetic acid 
(0.006 M). All substrates, cofactors, and assay enzymes 
were purchased from Sigma Chemical Company and used directly 
without further purification. None of the assay enzyme 
solutions were dialyzed, and all assay enzyme solutions were 
prepared daily. All substrates and cofactors were prepared 
on a weekly basis. Each assay was started with the super­
natant and was determined in duplicate at room temperature 
(25 ± 1°C). A blank was measured for each of the assay con­
ditions, and it was found that the activity of the blank 
ceased in two to five minutes. Sonication of the cells 
longer than two minutes significantly increases the oxida­
tion of reduced pyridine nucleotides and, thus, it was a 
necessity not to sonicate longer than two minutes.
Ihe following paragraph lists the millimoles (mM) 
of reagents added to a 3 ml assay, and the activity of the 
assay enzymes is given in units (U). One unit (U) of any 
enzyme is defined as "that amount of enzyme which will 
catalyze the transformation of one micromole of substrate 
per minute (1 7)."
1 . Glycéraldéhyde Phosphate Dehydrogenase (GAPDH)
a. 12 mM Sodium Arsenate
b. O.k- mM Diphosphopyridine Nucleotide (NAD'*')
c. 0.6 mM L Glyceraldehyde-3-Phosphate (GAP)
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2. Pyruvate Kinase (PE)
a. 10 mM MgCl2
b. 0.3 mM Reduced Diphosphopyridine Nucleotide (NADH)
c. 3*0 mM Phosphoenol Pyruvate (PEP)
d. 3«0 mM Adenosine Diphosphate (ADP)
e. 9*1 U Lactic Acid Dehydrogenase
f. Time must be allowed for any pyruvate in the 
phosphoenol pyruvate to be consumed
3. Phosphofructokinase (PEE)
a. 10 mM MgCl2
b. 0.3 mM NADH
c. 3*0 mM Adenosine Triphosphate (ATP)
d. 3*0 mM Fructose-6-Phosphate (F-6-P)
e. 1.0 U Aldolase
fo 7=1 U ol-glycerol phosphate dehydrogenase 
go l8o3 U Triosephosphate Isomerase 
h. Since two moles of NADH are oxidized per mole of 
substrate utilized, the observed rate has to be 
divided by two to express the measurement in U 
4-. Phosphoglycerate Einase (PGE)
a. 10 mM MgCl2
b. 0.3 mM NADH
Co 2.8 mM Cysteine
d. 2.8 mM 3-Phosphoglyceric Acid (3PGA)
e. 2.8 mM ATP 
fo 4.3 U GAPDH
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5. Hexokinase (HK)-'
a. 10 mM MgClg
b. 0 . 3 5 mM Triphosphopyridine Nucleotide (NADP"'")
c. 2,8 mM Glucose
d. 2.8 mM ATP
e. 4 . 3  U Glucose-6-Phosphate Dehydrogenase
6. Glucose-6-Phosphate Dehydrogenase (GPDH)
a. 10 mM MgCl2
b. 0 . 3 6 mM NADP"̂
c. 3*0 mM Glucose-6-Phosphate (G-6-P)
7 . 6-Phosphogluconate Dehydrogenase (6PGADH)
a. 10 mM MgCl2
b. 0 .3 6 mM NADP^
c. 3”0 mM 6-Phosphogluconic Acid
8. Phosphoglucomutase (PGM)
a. 20 mM MgCl2
b. 0 , 3 6 mM NADP"̂
c. 3"0 mM Glucose-1-Phosphate
d. ^ , 3  U GPDH
e. Evidently, glucose-1,6-diphosphate was present in 
adequate catalytic amounts
9. Lactate Dehydrogenase (LDH)
a. 0 , 3 mM NADH
b. 6.2 mM Pyruvate (Pyr)
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10. Aldolase
a. 0,3 mM NADH
b. 3*0 mM Fructose-1,6-Diphosphate
Co 7*1 U Glycerolphosphate Dehydrogenase
d. l8o3 U Triosephosphate Isomerase
e. The observed rate is divided by two (see PFK)
11. Phosphoglucoisomerase (PGI)
a. 10 mM MgClQ
b. 0.36 mM NADP^
Co 3-0 mM Fructose-6-Phosphate
d. 4.3 U GPDH
e. All of the G-6-P which contaminates the F-6-P is
consumed within one minute
12. Fructosediphosphatase (FDPase)
a. 10 mM MgClg
b. 0 . 3 6 mM NADP+
Co 3»0 mM Fructose-1,6-Diphosphate 
do 4 . 3  U GPDH 
Three of the enzymes that showed a statistical vari­
ation in their specific activities (expressed as millimicro­
moles of substrate utilized per minute per 10^ cells) for the 
two cell types and one that was not a statistical variant 
were selected for a more detailed kinetic study. For each
of the enzymes in both sources, a pH profile, saturation
curve. Hill plot (3), and Lineweaver-Burk plot (40) were 
determined. The pH profile was accomplished in all cases
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by using 50 mM tris buffers at pHs of 7 .00, 7 .2 5 , 7*50,
7 .7 5 , 8.00, 8 .5 0, 9 .0 0 , and 9*50 and 50 mM immidazole buf­
fers at pHs of 6.0, 6 .5 , 7*0 and 7*5* The pH of each buffer 
was adjusted immediately before using with the expanded 
scale of a Corning pH meter. Each assay had concentrations 
of substrates and cofactors as previously described, i.e.
Vjjj conditions. The data for the saturation curves. Hill 
plots, and Lineweaver-Burk plots were determined for each 
substrate by varying one substrate so that the lowest re­
action rate was at least 0.1 while the other substrates 
were maintained at enzyme saturating levels.
Also for the same four enzymes many of the glycolytic 
and tricarboxylic acid cycle intermediates were examined as 
possible affectors of enzymic rate. Since some of these 
compounds were capable of chelating magnesium ions, 20 mil­
limoles of MgCl2 added to a 3*0 ml assay. All of these 
compounds were purchased from Sigma Chemical Company.
CHAPTER IV
EXPERIMENTAL RESULTS
In Table 1 is presented the glucose consumption and 
lactate production by WI-38 and WI-38 VAI3A. Four indi­
vidual experiments were run and the average of triplicate 
determinations is recorded in Table 1. The average and 
standard deviations were determined using an Olivetti Under­
wood Programma 101 Electronic Desk Computer. The standard
  1 1 / 2deviation was computed by the formula, s=( 2 (x-x)/n-1) 
using a program card generously donated by Mr. Phillip 
Schafer.
TABLE 1.— Glucose consumption and lactate production in WI -38 
and WI -3 8 VAI3A. All values are expressed in 
micromicromoles per cell change per hour, 
s is the standard deviation
Glucose Consumed Lactate Produced
Attempt WI -3 8 WI-38 VA13A WI-3 8/ WI:-38. VAI3A
1 1.88 0 .7 3 4.10 1 .4 9
2 1 .9 9 0 .8 3 3.46 1 . 4 5
3 2 . 0 9 0 . 8 6 3 .3 3 1 .43
If 1.60 0.69 4.02 0 . 9 6
Avg. t s 1 .89±.21 0 .7 8 + .0 8 3 .7 8 1 .3 9 1.331.24
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Based on Table 1 several conclusions can be made by 
comparing the glucose consumption and lactate production of 
¥1-38 and ¥1-38 VAI3A. Since the ratio of lactate produc­
tion to glucose consumption is approximately 2.0 and 1 .7  
for ¥1-38 and ¥1-38 VAI3A, respectively, it is concluded 
that the predominate fate of glucose is lactate formation. 
Also the lactate production is about 2.7 fold greater in 
¥ 1 -3 8 , and glucose consumption is about 2.h fold greater 
in ¥1-38.
Located in Tables 2-A and 2-B are the concentra­
tions of each adenine nucleotide in ¥1-38 VA13A and ¥1-38, 
respectively. Each value is the average of triplicate de­
terminations with s being calculated as previously described.
TABLE 2-A.— Levels of adenine nucleotides in ¥1-38 VA13A. 
The levels are reported in millimicromoles per 10° 
cells, s is the standard deviation
Attempt ATP ADP AMP
1 18.6 11.1 ^0 « 8
2 1 6 .6 1 1 . 5 ^5 .3
3 15-0 1 0 . 5 3 3 .̂
If 1 6 .7 1 1 .9 ^0.1
Avg. + s 16.7±1. 5 1 1.3+0 . 6 3 9 .9+^.9
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TABLE 2-B.— Levels of adenine nucleotides in ¥1-38. The 
levels are reported in millimicromoles per 106 
cells, s is the standard deviation
Attempt ATP ADP AMP
1 7 . 0 19.5 84.8
2 5.1 15.8 68.4
3 10.1 17.1 78.0
8.4 1 8 .0 69.2
Avg. + s 7'7±2.1 1 7.6+1 .6 75.1*7.8
By comparison it is evident that ATP levels in 
¥1-38 are about 2 fold less than the ATP levels found for 
¥1-38 VAI3A. However, the AMP level is nearly 2 fold greater 
in ¥1-38 and the ADP level is about 1.5 times as large as 
in ¥1-38. The total concentrations of adenine nucleotides 
for each cell type indicates that ¥1-38 adenine nucleotide 
pool is nearly 1.5 fold larger than the ¥1-38 VAI3A adenine 
nucleotide pool. Furthermore when the percent concentra­
tion of each adenine nucleotide in the estimated pool is 
calculated, the following results are obtained for ¥1-3 8 :
7o7% ATP, 1 7.5^ ADP, and 7^-8^ AMP and for ¥1-38 VA13A:
24.8# ATP, 1 6.7^ ADP and 58*5^ AMP. Thus when expressed on 
the basis of percent of the total adenine nucleotide pool 
the percent ADP is nearly the same for both sources, but the 
ATP and AMP levels are significantly different.
Tables 3-A and 3-B show the enzyme patterns for 
¥1-38 and ¥1-38 VAI3A, respectively. Each value is the
3^
average of duplicate determinations and is calculated from 
the eight individual values by the manner previously de­
scribed. From Tables 3-A and 3-B it is discernible that all 
of the glycolytic enzymes except enolase and phosphoglycero- 
mutase were measured for both cell types as well as GPDH 
and 6PGADH of the phosphogluconate oxidative pathway and the 
gluconeogenic enzymes PGM and FDPase. It is apparent from 
Tables 3-A and 3-B that FDPase is the enzyme of lowest ac­
tivity in both sources. The low activity glycolytic 
enzymes are HK, PFK, and aldolase in both cell types. Com­
parison of Tables 3-A and 3-B show that both of the phos­
phogluconate oxidative pathway enzymes have a larger 
specific activity in ¥1-38 i.e. 2.1 and 1.6 fold greater 
specific activities of GPDH and 6PGADH, respectively. Also
the glycolytic enzymes HK, PGI, and GAPDH are statistically 
different in the two cell types. HK is about 2.h fold 
greater in ¥1-38, and GAPDH is about 2.1 greater in ¥1-38. 
However, the specific activity of PGI is about 1.3 fold 
higher in ¥1-38 VAI3A. Also the gluconeogenic enzyme FDPase, 
is approximately 3 fold greater in ¥1-38.
Since HK, GPDH, and GAPDH differed statistically 
in their specific activities for both cell types and PK was 
thought to be highly regulated in human cells, they were 
selected for further analysis. These enzymes were studied 
by determining their pH profiles and saturation curves.

















Table 3-A: Enzyme patterns in WI-38. Enzyme activities expressed in millimicromoles of substrate utilized per
minute per 10® cells, a  is the standard deviation.
1 2 3 4 5 6 7 8 Avg ± a
63.1 73.7 74.2 57.8 62.7 60.0 58.8 61.7 64.0 ± 6.5
8.7 9.2 9.6 7.2 7.7 7.7 8.7 6.8 8.2 ± 1.0
4.3 3.7 3.1 4.3 5.3 3.1 3.9 3.6 3.9 ± 0.7
12.5 15.4 14.5 13.5 11.1 12.1 14.0 10.6 13.0 ± 1.7
247 210 212 222 298 323 242 266 253 ± 41
.
0.96 1.06 2.51 1.54 1.40 1.49 2.07 1.35 1.55 ± 0.51
11.5 10.5 13.5 11.1 8.5 11.5 12.5 10.5 11.2 ± 1.5
71.3 72.8 75.2 71.8 58.8 81.9 68.9 79.5 72.5 ±7.0
242 246 269 274 350 376 286 246 286 ± 50
252 252 234 198 252 209 215 220 229 ± 22

















Table 3-B: Enzyme patterns in WI-38 VA13A. Enzyme activities expressed in millimicromoles of substrate utilized
per minute per 10® cells.
1 2 3 4 5 6 7 8 Avg * G
31.3 33.3 30.4 30.3 32.3 29.4 30.4 30.4 30.9 ± 1.4
4.8 5.8 5.7 4.4 4.4 5.2 5.7 4.8 5.1 ± 0.6
•3.0 4.2 2.7 3.6 2.2 3.4 4.6 3.9 3.5 ± 0.8
5.8 4.8 4.8 5.8 6.3 5.8 6.3 4.8 5.5 ± 0.6
276 315 381 369 330 342 303 341 332 ± 32
7.7 10.5 11.6 9.2 10.1 8.0 10.6 7.2 9.4 ± 1.6
0.48 0.54 0.59 0.48 0.64 0.48 0.59 0.54 0.54 ± 0.06
16.1 16,4 15.9 13.0 16.7 14.2 12.1 14.9 14.1 ± 2.0
32.7 28.0 28.4 39.0 40.5 35.2 41.5 29.9 34.4 ± 5.5
299 238 261 319 351 402 307 342 315 ± 52
256 242 250 240 271 256 265 249 254 ± 11
270 367 243 260 283 379 377 332 314 ±'56
Os
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Lineweaver-Burk plots (^0) and Hill plots (3) were made, 
and these results are compared between the two sources in 
order to determine the extent of similarity between the 
various parameters.
From the Hill plots an interaction coefficient can 
be determined. The interaction coefficient is a reflection 
of the minimal number of substrate molecules that can be 
assumed to interact with an enzyme molecule. However, the 
interaction coefficient is only greater than one when the 
ligand binding shows cooperative interactions with other 
ligand binding sites, i.e. binding of each ligand affects 
further binding of another ligand. The interaction coef­
ficient is a true measure of the order of the enzymic re­
action only when binding site interactions occur and when 
the concentrations of any complexes containing fewer than n 
ligands is negligible compared to the ESĵ  complex. From the
equation log ^ = n log (S) - log K, where v is the reac-Vm-v
tion velocity at a substrate concentration of S, is the 
maximum attainable velocity, and n is the interaction coef­
ficient, the interaction coefficient can be determined 
graphically. This is accomplished by plotting the values 
for ÿ Yv versus (S) on full logarithmic paper which results 
in the generation of a straight line whose slope is the 
interaction coefficient. Table h lists the interaction co­
efficients for the enzymes studied. When possible the values
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for the reaction rates were selected between 0.1 and 0.9 
for the Hill Plots.
TABLE ^.--A list of the Interaction Coefficients. Abbrevia-






GPDH G-6-P(<0.0^5mM) 0.85,0.95 0 .7 6,0 .8 0
GPDH G-6-P( >0.^5mM) 2 .0 ,1.8 2.0,1.8
GPDH NADP+(<. O.IOmM) 0 .8^,0 . 7 5 0 .9 0,0 .8 8
GPDH NADP+OO.IOmM) 1.8 ,1 .9 2.2,2.0
HK ATP 0 .9 6,1 .0 0 .8 7,0 . 9 5
HK Glucose 1.0,1.0 0 .9 8,1 .0
GAPDH GAP 1.5 ,10^ 1 .5 ,1 . 5
GAPDH HAD+ 1.0,1,0,1.2 1.^,10^,1,5
PK PEP 1.8,2.0 1 .8 ,2 . 0
PK ADP 1 .7 ,2 . 0 1.8,2.0
As can be seen from Table 4, the interaction coef­
ficients for nearly all of the substrates are approximately 
identical for each enzyme regardless of the source. The 
only possible exception is the NAD"*" interaction coefficients 
for WI-38 and WI-38 VAI3A. The NAD'*' interaction coefficient 
for WI-38 was always found in 3 independent determinations 
to be less than the one for WI-38 VA13A.
Table 5 is a tabulation of the optimum pH for each 
enzyme. All values were determined under substrate
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saturating conditions using the buffers as described in 
Chapter III. The pH profiles for each enzyme from both cell 
types were nearly superimposable in all cases and the opti­
mum pHs were identical in both types of cells. For HK two 
peaks of the pH profile were found, one at 7*7 and the other 
at 9*0. The peak at pH 9-0 was also the pH optimum for the 
assay enzyme GPDH, and it was found that at a pH of 9»0 the 
GPDH utilization of glucose was greater than at any other 
pH. Thus the NADPH production that was measured was the 
summation of utilization of the G-6-P produced by HK as well 
as the glucose present in the assay. By using a blank to 
measure glucose dehydrogenase activity of the assay enzyme 
at pH 9"0, it was found that pH 7*7 was the true pH optimum.
TABLE 5-— pH Optimum. Abbreviations may be found in
Chapter 111
Enzyme
pH Optimum for 
WI -38 WI-38 VAI3A
GPDH 8 . 0 8 . 0
HK 7 . 7  (9 .0 ) 7 . 7  (9 .0 )
GAPDH 7 . 8 7 . 8
PK 7 . 2 7 .2
In Figures 1 through 25, all saturation curves and 
Lineweaver-Burk plots are given for HK, GPDH, GAPDH, and 
PK for WI -38 and WI-38 VAI3A. For GPDH in both cell types, 
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Figure 1: Glucose saturation of HK from *1-38 and corresponding
2.0
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Figure 2: Glucose saturEition of HK for WI-38 VA13A and corresponding













Figure 3; AT? saturation of HK from WI-38 and corresponding Lineweaver- 














Figure 4: ATP saturation of HK from WI-38 VA13A and corresponding
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Figure 5; G-6-Psaturâtion of GPDH from WI-38. Solid lino is determined by
experiment and dashed lines are extended to simulate overlapping saturation 














Figure 6; Lineweaver-Burk Plot of G-6-P saturation of 
WI-38 GPDH.G-6-P concentrations greater than 0.10 mM must 
be squared and are reported in top curve. G-6-P levels less 
than 0.10 mM are reported in lower curve. Abbreviations 
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Figure 7; G-6-P saturation of GPDH from WI-38 VA13A. Solid line is
determined by experiment, and dashed lines are extended to simulate 
overlapping saturation curves of two GPDH isozymes. Abbreviations 
found in Chapter III.
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Figure 8: Lineweaver-Burk Plot of G-6-P saturation of
WI-38 VA13A GPDH. G-6-P concentrations greater than 0.10 
mM must be squared and are reported in top curve. G-6-P 
levels less than 0.10 mM are reported in lower curve. 


























Figure 10: NADP^ saturation of GPDH from WI-38 VA13A.
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Figure 11: GAP saturation of GAPDH from WI-38. Abbreviations in
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Figure 12: GAP saturation of GAPDH from WI-38 VA13A. Abbreviations
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Figure 13: NAD saturation of GAPDH from WI-38. Abbreviations
found in Chapter III. Inset is the Lineweaver-Burk Plotv 
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Figure 14: NAD* saturation of GAPDH from WI-38 VA13A and
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Figure 15: Effect of ATP on PEP saturation of PK from WI-38.
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Figure 16; Effect of Lp&lanine on PEP saturation of PK from WI-38. 
Abbreviations found in Chapter III.
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Figure 17: Effect of L-alanine (top curve) and ATP
(lower curve) on Lineweaver-Burk Plot for PEP 













Figure 18: Effect of L-alanine and ATP on PEP saturation of PK from











Figure 19: Effect of L*alanine and ATP on
Lineweaver-Burk Plot for PEP saturation of PK from 
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Figure 20: Effect of FDP on PEP saturation of PK from WI-38 VA13A.
Abbreviations found in Chapter III. Inset is the Lineweaver-Burk Plots 
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Figure 21: Effect of ATP on ADP saturation of PK from WI-38.
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Figure 22: Effect of L-alanine on ADP saturation of PK from WI-38.
Abbreviations found in Chapter III.
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Figure 23: Effect of L-alanine (top curve) and ATP
(lower curve) on Lineweaver-Burk Plot for ADP saturation:of 
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Figure 24: Effect of ATP on ADP saturation of PK from WI-38 VA13A.
Abbreviations found in Chapter III. Inset is the Lineweaver-Burk Plots 
corresponding to the saturation curves.
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Figure 25: Effect of L-alanine on ADP saturation of PK from WI-38 VA13A.
Abbreviations found in Chapter III. Inset is the Lineweaver-Burk Plots 
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Figure 26: Activation of PK from WI-38 and WI-38 VA13A by













Figure 27: Desensitization of PK from WI-38 VA13A to FDP activation
by storage at -20°C. Abbreviations found in Chapter III.
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than 0 , 0 8 mM had to be squared in order to generate a straight
-  "  %  A "  + %
reason for this operation as well as its implications will
line from the Lineweaver-Burk equation, — = —  Ihe
be explained in the discussion. Also for GPDH from both 
sources reciprocals of the concentration of NADP had to be 
squared in order to obtain a straight line from the 
Lineweaver-Burk equation. Also, for PK from both sources the 
reciprocal values of the concentrations of both substrates 
had to be squared in order to generate a straight line from 
the Lineweaver-Burk equation. The assays for each enzyme 
were made as outlined in Chapter III except that one sub­
strate is varied over the concentration range given on the 
abscissa of each saturation curve.
Table 6 is a tabulation of the kinetic constants that 
can be determined from Figures 1 through 25*
By comparing the Michaelis Constants (K^) tabulated 
in Table 6 , it is evident that the Kĵ ’s are nearly identical 
with a few exceptions. The of NAD'̂  for GAPDH seems to be 
different for the two cell types. For WI-38 the is 
0.065 mM and 0.085 mM and for WI-38 VAI3A the E^ is 0.250 mM 
and 0 .2 5 6 mM as determined from the saturation curve and 
Lineweaver-Burk plot, respectively. For PE the range of 
Ê '̂s for ADP varies significantly in both cell types, and 
E^ is dependent on the method of estimation. However, the 
Ejjj for ADP is about the same for each cell type when de­
termined by identical methods. Since the Em determination
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is less valid for the saturation curve, the Kjjj from the 
Lineweaver-Burk plot is probably the more valid K^.
TABLE 6 0— Kinetic Constants tabulated for Figures 1-25- 
Abbreviations may be found in Chapter III. Michaelis 








HK Glucose WI -38 0 .0 1 3 0.012
HK Glucose WI -38 VAI3A 0.012 0.014
HK ATP WI-38 0.012 0.011
HK ATP WI-38 VA13A 0 .0 1 0 0.011
GPDH G-6-P<0o08mM WI-38 0 .0 0 9 0 .0 1 2
GPDH G-6-P>0.08mM WI-38 0.04D 0 .0 3 9
GPDH G-6-P<0.08mM WI -38 VA13A 0 .0 1 2 0.014
GPDH G-6-P>0.08mM WI -38 VA13A o.o4o 0 .0 3 9
GPDH NADP+ WI -38 0 .0 1 6 0 . 0 1 5
GPOH NADP+ WI-38 VA13A 0 .0 1 2 0.014
GAPDH GAP WI -38 0 .3 4 0 0 .3 3 3
GAPDH GAP WI-38 VAI3A 0 .3 2 0 0 .2 9 0
GAPDH HAD+ WI-38 0 .0 6 5 0.085
GAPDH NAD+ WI-38 VAI3A 0 .2 5 0 0 .2 5 6
PK PEP WI -38 0.260 0 .2 5 9
PK PEP WI -38 VAI3A 0 .2 8 0 0 .2 5 9
PK ADP WI -38 0.400 0 .3 0 0
PK ADP WI -38 VAI3A 0 .3 8 9 0 .3 0 0
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Figure 26 shows the activation effect of potassium 
ions on PK from WI-38 and WI-38 VAI3A 0 This activation is 
determined in both sources by using a cell extract that had 
been sonicated in O.05OM tris buffer at pH 7-6, centrifuged, 
and dialyzed (^000^ against tris buffer, (pH 7 .6 ). The 
procedure for obtaining a cell free preparation is identical 
to the one used for the enzyme assays except that tris buffer 
is substituted for the extraction solution. The assay 
method used is outlined in Chapter 111.
As is noted from Figure 26, the KOI saturation 
curves for WI-38 and WI-38 VAI3A are nearly superimposable. 
For both sources it is evident that the enzyme saturating 
level of KOI is about 50 mM for both types of cells.
In Figure 27 are shown the desensitization studies 
performed on PK from WI-38 VAI3A. The cell free prepara­
tion was obtained as described in Chapter 111, and then the 
activity was measured immediately for day zero. The cell 
free preparation was divided into five aliquots, was frozen 
at -20®C, and was assayed on the days shown on the abscissa. 
The cell free preparation which was assayed immediately 
showed a 2.6^ fold stimulation at 1.0 mM FDP. This stimu­
lation rapidly dropped upon storage at -20°C. After storage 
for 2h hours the FDP induces only a 1.35 fold stimulation. 
During the following days the activity of PK in the frozen 
solutions decreased, but the degree of activation remained 
reasonably constant. For example, the activation by FDP
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was 1 .3 5? 1 .3 6 , 1 .3 8, 1 .3 9, and 1.4-8 fold after being frozen 
for 2 , 4, 7 , and 8 days, respectively.
Table 7 is a compilation of the results of a com­
prehensive study which was made to find any modifiers of 
enzymatic activity that occur in these cell types. These 
results indicate that with the exception of the substrates 
none of the listed compounds affected the activity of HK.
For PK, ATP and L-alanine proved to be inhibitory 
at enzyme saturating levels of PEP and ADP. With respect 
to PEP, the inhibition by ATP (1.0 mM) was 58^ and 47^ and 
by L-alanine (1.0 mM) was 52^ and 70^ for WI-38 and WI-3 8- 
VAI3A, respectively. With respect to ADP, the inhibition 
by ATP (1.0 mM) was 65% and 16% and by L-alanine (1.0 mM) 
was 55%o and 4l^ for WI-38 and WI -38 VAI3A, respectively.
From Figures 17 and 19 it is evident that both ATP and 
L-alanine are non-competitive inhibitors with respect to 
PEP, and from Figures 23, 24, and 25 it is also evident that 
ATP and L-alanine are non-competitive inhibitors with re­
spect to ADP regardless of the cell type. Also, KOI and FDP 
were shown to be activators of PK, 10 and 2 fold, respec­
tively. As was discussed earlier PK from both cell types 
is strongly activated by KOI (see Figure 26), and as shown 
in Figure 20, FDP is a non-competitive activator of PK with 
respect to PEP.
For GAPDH only the adenine nucleotides (AMP, ADP, 
and ATP) affected enzymic activity. The degree of inhibition
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TABLE 7'--Effect of selected compounds on the activity of HK, 
PK, GAPDH, and GPDH. Abbreviations and assay condi-
were 1.0 mM in the assay
Compound HK PK GAPDH GPDH
Glucose Substrate No Effect No Effect No Effect
G-6-P No Effect tl II Substrate
R-5-P II tl II No Effect
F-6-P II It tl II
FDP II Activator tl II
GAP II No Effect Substrate II
3-PGA II II No Effect II
2-PGA II II II II
PEP Substrate II II
Pyruvate —— --— --- II
Lactate II — - - - --- II
Citrate II No Effect No Effect II
Isocitrate II It II II
Of Ketoglutarate II II II II
Succinate II II II II
Fumarate II II II II
Malate II It II II
Oxaloacetate - - - - - - - - - - - - - - - II
ATP Substrate Inhibitor Inhibitor II
ADP No Effect Substrate II II
AMP tl No Effect It II
3' -5' Cyclic
AMP !t II No Effect II
Inorganic 
Phosphate • Tl II Substrate Inhibitor
L-alanine tl Inhibitor No Effect No Effect
KCl IT Activator II II
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was not dependent on the degree of phosphorylation of the 
adenine nucleotide. At half saturating levels of GAP or 
NAD^ the adenine nucleotides (1.0 mM); inhibited GAPDH by 
25 to 30#; and at enzyme saturating levels of both sub­
strates these adenine nucleotides (1.0 mM) inhibited GAPDH 
by 10 to 12^.;
Also from Table 7 it can be observed that GPDH 
except for G-6-P was affected only by inorganic phosphate 
(1.0 mM) which inhibits about 30^ at substrate saturating 
levels of the enzyme.
The effect of pyruvate on HK, PK, and GAPDH, the 
effect of lactate of PK and GAPDH and the effect of 
oxaloacetate (QAA) on HK, PK, and GAPDH were not reported 
because the presence of these compounds in the assay solu­
tion complicated the measurement of enzyme activity.
Pyruvate and lactate complicate the PK and GAPDH assays by 
utilizing any NADH or NAD^, respectively, since high LDH 
activity is present in the assay. Why pyruvate complicates 
the HK assay is unclear. However, the appreciable disap­
pearance of absorption at 3^0 mM that was observed in the HK 
blank could be due to endogenous NADH or conversion of any 
NADPH to NADH by the cell-free preparation. The NADH could 
then be used by any LDH in the assay. Since LDH activity 
could not be demonstrated in the presence of pyruvate and 
NADPH, a NADPH specific LDH is not complicating the assay. 
The effect of QAA on the PK and GAPDH activity was due to
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the ability of LDH to use OAA as a substrate. The effect of 
OAA on the HK reaction is also unclear. However, it is 
thought that the effect is not an inhibition of HK, but a 
utilization of the HADPH produced by the coupling enzyme. 
Probably the OAA or some conversion product is utilizing the 




Since the molar ratio of lactate production to glu­
cose consumption is nearly 2 for each source, it is reason­
able to assume that the ultimate fate of glucose is 
predominately lactate formation. These results agree with 
the general concept that cultured cells exhibit a relatively 
high aerobic glycolysis rate and a relatively low respira­
tory rate (39).
Kruse and Miedema (3 7) have reported a glucose uptake 
of 0 .32^ ± 0 ,0 7 7 micromicromoles/hr/cell and a lactate pro­
duction of 0 .33^ ± 0 .0 9 9 micromicromoles/hr/cell for WI -38 
cultured under perfusion conditions. In a personal communi­
cation (3 6) Kruse has related a glucose uptake of 
0 .2 3 3 ± 0 .0 9 9 micromicromoles/hr/cell and a lactate produc­
tion of 0 . 3 5 5 t 0 .0 9 9 micromicromoles/hr/cell for WI-38 VAI3A 
cells that were cultured under perfusion conditions. Kruse 
and Miedema do not demonstrate a statistically significant 
difference between the two cell types, but considering only 
the average, WI-38 shows a higher lactate production and 
glucose utilization. However, the data presented in Table 1
7^
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show that the glycolysis rate of WI -38 is statistically 
greater than that of WI-38 VA13A. Also a comparison of the 
magnitude of the data in Table 1 with that of Kruse and co­
workers (3 7 ) and Cristofalo and co-workers (I6 ) indicates 
that the data in Table 1 are about 10 fold greater than 
their data. It should be emphasized that Kruse and 
Cristofalo cultivated their cells under perfusion conditions 
while we used stoppered bottle cultivation. Therefore, it 
is probable that the difference in the data is a consequence 
of the method of cell cultivation.
As was discussed in Chapter I, cells transformed by 
Rous sarcoma viruses (52) have the same glycolytic capacity 
as uninfected cells, but the transformed cells exhibit a 
greater growth potential than the untransformed cells. Also, 
polyoma transformed cells exhibit a two fold greater glucose 
consumption than the untransformed cells (9). It is evident 
from a comparison of the glycolysis data of this work with 
glycolysis data from other non-transformed - transformed 
cell pairs that the viral transformations which were dis­
cussed do not have the same effect on the glycolysis rate. 
Seemingly, the effect of viral transformation on glycolysis 
is dependent on the transforming virus and probably on the 
host cell. Considering the magnitude of differences be­
tween the glycolytic rates (10) of rat liver and rat 
hepatomas, it can be seen that the advanced hepatoma 
glycolytic rate is 15 times the host liver whereas the
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sub-minimal and minimal hepatoma’s glycolytic rate is 2 to 3 
times that of the host liver. Thus, the magnitude of change 
in glycolysis rate due to viral transformation by polyoma and 
SYhO viruses is relatively small, and it is comparable to the 
magnitude of change for minimal hepatomas compared to host 
liver. However, the 8V4o transformed cells do not conform 
to the concepts of Warburg that malignancy is associated 
with increased fermentation (5 6).
By taking the glucose consumption and HK levels for 
both cell types from Tables 1, 3-A, and 3-B, Table 8 can be 
constructed:
TABLE 8 ,— Comparison of the HK levels and glucose consumption 
for WI-38 and WI -38 VA13A, The HK levels are given in 
millimicromoles of glucose utilized per minute per 
106 cells, and the glucose consumption is given 






WI-38 13.0 ± 1 .7 1 .8 9 ± 0.21
WI-38 VAI3A 5 .5  ± 0 . 6 0 .7 8 ± 0 .0 8
Ratio ■ WI-38WI-38 VAI3A 2.36 2 .Î+2
A comparison of the ratios for HK levels and glucose con­
sumptions demonstrates that the correlation is striking and 
tempts one to explain the difference in glucose consumption 
on the basis of the HK level differences. This speculation 
is further strengthened by the data in Tables 3-A and 3-B
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which indicate that HK is a low activity enzyme and under 
the proper conditions could be the rate limiting glycolytic 
enzyme. Therefore, the rationale for the explanation of the 
observed differences in the glucose consumption for ¥1-38 
and ¥1-38 VA13A is well founded on the basis of HK levels. 
Thus, an explanation based on a viral induced change in the 
cell membrane which results in retardation of glucose 
permeability is unnecessary. An increase in glycolysis due 
to increased HK levels has also been found for other cells. 
For example, in advanced rat hepatomas increased glycolytic 
rate can be correlated with an increased level of HK (440.
In order to understand better the metabolic state of 
both types of cells, the intracellular concentrations of the 
adenine nucleotides (ATP, ADP, and AMP) were determined. The 
results of this study are presented in Tables 2-A and 2-B. 
These results show that ¥1-38 has the larger total adenine 
nucleotide pool and that the distribution of the particular 
nucleotide types is significantly different in the two cell 
sources. The lower level of adenine nucleotides in the 
viral transformed cell may be due to cellular leakage, de­
pressed biosynthesis of adenine nucleotides, or increased 
catabolism of adenine nucleotides. Of the three possi­
bilities none is particularly favored. Since respiration 
is relatively low in both cell types (1 8), it is probable 
that the regeneration of ATP is very low. Thus, the dif­
ferences observed in the ATP levels may be due to greater
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consumption of ATP in WI-3 8 . The greater ATP consumption in 
WI -38 could he due to one or more of the following reasons: 
(1) An increased protein synthesis (Miedma and Kruse (43) 
report high initial levels of protein in WI-3 8); (2) in­
creased nucleotide transphosphorylation; and (3) increased 
ATP requiring ion translocation mechanisms. Another possi­
bility which is based on experimental evidence that may 
contribute to the lower levels of ATP in WI-38 is the 3 fold 
greater activity of alkaline phosphatase in WI-38 compared 
to WI -38 VA13A (1 8).
In accordance with the concept of adenylate regu­
lation of glycolysis (2) the higher ADP and AMP levels 
coupled with the decreased ATP levels are postulated to con­
tribute to the higher glycolytic rate in WI-38 synergistic 
with the increased level of HK and GAPDH. This postulated 
difference in glycolysis is based on inference from work in 
other tissues (13, 29), but actual work will have to be per­
formed on WI-38 in order to show the existence of AMP and/or 
ADP activation and of ATP inhibition of PFK as well as AMP 
inhibition of FDPase.
Of the enzymes investigated only EK, FDPase, GAPDH, 
GPDH, and 6PGADH are statistically different in WI-38 and 
WI -38 VAI3A, In general, HK, GAPDH, and GPDH are 2 fold 
greater in WI-3 8 while 6PGADH is about 1,5 fold greater in 
WI-3 8 , and FDPase is about 3 fold greater in WI-3 8 . Al­
though the statistical difference in specific activity of
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PGI from both cell types is questionable, the PGI activity 
appears to be greater in ¥1-38 VA13A. In a similar study on 
WI-38 and WI-3 8 VAI3A cells cultured in a perfusion system 
Cristofalo (l43 also reports a higher activity of PGI in 
WI-38 VAI3A as well as a greater activity (2 fold) for 
6PGADH and transaldolase. He does not report significant 
differences for other glycolytic enzymes. No plausible 
explanation can be offered at this time for the differences 
observed between the two laboratories except that the cells 
were cultured by different methods. A related study on 
polyoma transformation (46) has shown that for the trans­
formed cells HK, NADP’*' specific isocitrate dehydrogenase, 
and NAD'*' specific malate dehydrogenase specific activities 
are 2-3 fold greater than the non-transformed cell. However, 
GPDH activity in the non-transformed cell is 1-2 fold greater 
than in the transformed cell. Also, they found no statisti­
cal differences between the two sources for 6PGADH and LDH.
In another related study on Rous sarcoma viral transforma­
tion (5 8) no significant differences in the specific 
activities of FDPase, GPDH and 6PGADH when compared to the 
host tissue are observed. However, for the viral transformed 
cell the specific activities of PGM, LDH, and PGI were 4 fold 
greater than in the non-transformed cells. From these data 
it is evident that no consistent trend in enzyme patterns 
which have been altered by viral transformation, can be 
shown at this time. Perhaps, when more information on the
80
enzyme patterns of various viral transformed and non- 
transformed cells is known, more generalizations can be made.
Even though the results in Chapter IV indicate that 
the enzymes showing statistically significant difference in 
activity from WI-38 and WI-38 VA13A do not exhibit any dif­
ference in substrate affinities (Kjjj's) or pH profiles (with 
the possible exception of GAPDH), synthesis of a kinetically 
more active enzyme in WI-38 is possible and cannot be ruled 
out as a possible explanation. However, recent work (6 ) 
using enzyme-electrophoresis and enzyme immunoelectrophoresis 
indicates that GPDH for both sources is identical but that 
LDH from the two sources had different electrophoretic pat­
terns. Thus, at least for GPDH the increase in specific 
activity is probably due to increased biosynthesis and this 
conclusion may very likely be extended to the other enzymes 
(6PGADH, HK, GAPDH, and FDPase). To explain the variation 
in enzyme levels between the two kinds of cells two possi­
bilities exist: (1 ) the enzyme level is depressed in the
transformed cell or (2 ) the enzyme level in the non- 
transformed cell is able to change for some reason and the 
transformed cell does not change. For example, Kruse (43) 
has shown for WI-38 that the activities of LDH and GPDH in­
crease 3 fold after the cell sheet becomes confluent when 
compared to pre-confluent cells. The corresponding studies 
on WI-38 VAI3A were not performed, but if it could be shown 
that the corresponding WI -38 VAI3A enzyme levels did not
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change with confluency, a plausible explanation for the 
difference in enzyme levels might be formulated. Two pos­
sible explanations for the effect of confluency on enzyme 
levels could be that the nutritional state of the medium of 
confluent cells is more depleted and induces an increased 
enzyme biosynthesis (this could be eliminated by perfusion 
techniques) or that the actual contact of the cells allows 
for the increased enzyme biosynthesis. Thus, the enzyme 
levels in WI-38 VAI3A might not be altered by the nutri­
tional state since it has been shown that the transformed 
cell is less limited by the nutritional state of the media 
than WI -38 or possibly the different outer cell membrane of 
the SV̂ -0 transformed cell does not permit induction of the 
enzymes. Even though the available data do not favor re­
pression of certain enzymes in WI-38 VAI3A, enzymic re­
pression cannot be ruled out as a possible answer to the 
cause in enzyme differences.
Since PGI activity is greater in WI-38 VA13A, one 
cannot imply that this enzyme activity is always greater in 
WI-3 8 . However, the higher PGI activity in the transformed 
cell may be a fortuitous alteration if not an adaptation 
mechanism. The higher PGI and lower GPDH activities in 
WI-38 VAI3A would suggest that a larger fraction of the 
available G-6-P will be glycolyzed in WI-38 VA13A than used 
in the hexose monophosphate shunt. Since less G-6-P is 
theoretically formed in WI-38 VA13A, the differences
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observed for these two enzymes may be necessary to insure 
sufficient glycolysis; thus, providing their "survival edge" 
over any other virus transformed cells which do not have 
this alteration. Some theoretical calculations, which may 
approximate the "in vivo" conditions, can demonstrate this 
hypothesis more vividly. By adding the activities of PGM, 
PGI, and GPDH and dividing the total into the activity of 
PGI, the fraction of G-6-P converted to F-6-P can be esti­
mated. The fraction of G-6 -P converted to F-6-P is 0.79 for 
WI-3 8 and 0 .9 1 for WT-38 VAI3A, This suspected lesser 
utilization of the hexose monophosphate shunt probably re­
sults in a reduced production of its products. This could 
result in less ribonucleic acid production due to lack of 
the precursor ribose-5-phosphate and could retard any me­
tabolism which uses reduced triphosphopyridine nucleotide.
From Table 3--̂  and 3-B, it can be seen that aldolase 
controls triose phosphate formation and that GAPDH, even 
though of intermediate activity, appears to limit the rate of 
triose phosphate utilization for both cell classes. Conse­
quently, the greater activity in WI-38 could give this cell 
a greater capacity for triose phosphate utilization than 
WI-3 8 VA13A and may then act synergistically with the in­
creased HK, AMP, and ADP levels and decreased ATP levels to 
at least partly explain the increased glycolytic rate in 
WI-3 8 .
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In general, any difference in the specific activities 
of the statistically different enzymes is manifested as a 
2 fold higher activity in WI-3 8 . This 2 fold increase re­
sults in an approximately 2 fold increase in glycolysis. The 
cause of the relative increase in enzyme activity in WI-38 
may be due to synchronous induction of these enzymes in 
WI-38 or synchronous repression in WI -38 VA13A. This be­
havior is similar to the results which led to the concept 
of functional genic units proposed by Weber, et al. (62).
It is interesting to compare the enzyme patterns of 
adult human lung (2 1 ) with the human embryonic lung tissue 
cultures, WI -38 and WI-38 VA13A (see Table 9)•
TABLE 9"— Order of increasing glycolytic enzyme activity for 




Lung WI-38 WI-38 VAI3A
1 PFK PFK HK
2 Aldolase Aldolase PFK
3 HK HK Aldolase
4 GAPDH GAPDH GAPDH
5 LDH LDH PK
6 PGK PGI LDH
7 PK PK PGK
8 PGI PGK PGI
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The lines in Table 9 divide the listed enzymes into three 
groups based on activity. These are arbitrarily designated 
high, intermediate, and low activity groups. The first three 
enzymes (HK, PFK, and Aldolase) fall into the low activity 
group while GAPDH falls into the intermediate group and is 
about 6 times as active as the low activity group enzymes.
The last four enzymes which are about 4 to 5 fold greater 
than GAPDH are the high activity enzymes. From the compari­
son made in Table 9, it can be concluded that the enzyme 
levels within each activity group can change, e.g. as a 
result of viral transformation or of differentiation but 
that the enzymes generally found in̂  each activity group do 
not change their group as a result of adaptation to tissue 
culture, viral transformation or differentiation.
Even though most of this discussion has been 
strongly slanted towards glycolysis, some comments on the 
effect of 81/40 transformation of WI-3 8 on gluconeogenesis 
can be made. By comparing Tables 3-A and 3-B it is apparent 
that the FDPase activity in WI-38 is 3 times greater than 
the WI-38 VAI3A enzyme. This 3 fold increase could lead to 
a greater rate of storage of glycogen in WI-3 8 , but com­
parison of the glycogen levels in WI -38 and WI-38 VAI3A 
would have to be made as well as a comparison of the gluco­
neogenic enzymes, pyruvate carboxylase and PEP carboxy- 
kinase, to prove this speculation.
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As was related in Chapter IV, the statistically dif­
ferent glycolytic enzymes (HK and GAPDH) as well as GPDH and 
PK were studied. This was done by determining their pH pro­
files and kinetic constants.
Hexokinase has a pH profile that is nearly super- 
imposable for both cell sources as well as identical optimum 
pHs (7-7) • Another pH optimum at pH 9*0 was found, but this 
is the glucose dehydrogenase activity of the assay enzyme 
GPDH. By comparing the Kĵ 's in Table 6 for both cell types, 
it is evident that the HK from both cells is kinetically 
identical. By examining Table 4, it is indicated that the 
interaction coefficients for both substrates are nearly one, 
and thus, no interacting binding sites are found for HK. 
Table 7, indicates that of the compounds tested only the 
substrates affected the activity of HK. The lack of any 
affect by G-6-P on HK was surprising since G-6-P inhibition 
of HK has been found in a variety of sources (rat heart 
(2 1 ), rat brain (3 2 ), human erythrocytes (4^), and ascites 
tumor cells (55))° Comparison of the K̂ '̂ s for ATP and glu­
cose with the above sources indicates that the HK in the 
human embryonic lung is much more sensitive to its sub­
strates. For example, the glucose K^ for rat tissue was 
0.045 mM which is 3 fold greater than the human embryonic 
lung tissue, and the K^ for ATP is about 0.5 mM in ascites 
cells as well as rat cells which is forty fold greater.
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GAPDH from WI -38 and WI -38 VA13A has pH profiles 
that approximately overlap and that exhibit the same pH opti­
mum (pH 7*8). A physically similar type of curve has been 
reported for GAPDH from rabbit muscle, heart, and liver (7 ), 
but the pH optimum is much higher in rabbit tissues 
(pH 8 .5-8.8 ). Comparison of the interaction coefficients in 
Table 4 indicates that the GAP coefficients are identical 
for both sources (1.5), and comparison of the NAD"*" coeffi­
cients indicates a small but definite difference is found 
for WI-38 (1.0 to 1.2) compared to WI-38 VAI3A (1.4 to 1.5)« 
From Table 6 it can be observed that the Kjjj for GAP is very 
close for both sources (0.29 to 0.3*+ mM) ; however, the 
for NAD'*’ is 3 to 4 fold less in WI-38 (0.065 to 0.085 mM) 
than in WI-3 8 VA13A (0.28 to 0.26 mM). From examination of 
the insets of Figures 11-l4, it is evident that the recipro­
cal values of the GAP concentration have to be squared in 
order to obtain a straight line for WI-38 VAI3A from GAPDH.
By combining this information with the Kĵ  and interaction 
coefficient data, it is evident that the affinity and binding 
site interactions are different between the WI-38 and 
WI-38 VAI3A enzyme. This could be due to synthesis of a 
different enzyme by the viral transformed cell that has ap­
proximately the same affinity for GAP but has a greater 
interaction of GAP binding sites. This would explain why 
the reciprocal values of GAP concentration must be squared 
for the Lineweaver-Burk plot. Also, this viral induced
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enzyme has a reduced affinity for NAD'*' and possibly less 
interaction of the NAD'*' binding sites. However, I feel that 
since the protein concentration in the WI-3 8 sonicate is 
less than in the WI -38 VAI3A sonicate, more dissociation of 
the enzyme could occur in the WI -38 sonicate which may 
explain the difference in the kinetic parameters for both 
sources. Deal (19) has shown rabbit muscle GAPDH is dis­
sociated faster by ATP at lower protein concentrations 
(0.1 mg/ml). If the degree of dissociation of GAPDH from 
WI -38 is the explanation of these results then the implica­
tion is that the NAD^ affinity of the dissociation products 
is greater than that of the whole enzyme and since the spe­
cific activity of GAPDH is greater in WI -38 (see Tables 3-^ 
and 3 -B) it is possible that the dissociation products are 
catalytically more active. Another factor that suggests 
enzymic dissociation is the necessity of squaring the re­
ciprocal values of the concentration of GAP for the 
Lineweaver-Burk plot for WI -38 in order to produce a straight 
line. Thus, it seems that interaction of the GAP binding 
sites is reduced which is what might be expected as a result 
of enzymic dissociation.
In Table 7 it is shown that with the exception of 
the substrates only the adenine nucleotides (AMP, ADP, and 
ATP) affect the rate of GAPDH. The extent of this inhibi­
tion is dependent on the concentration of its substrates.
At one-half saturating levels of GAP or NAD'*', the adenine
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nucleotides (1.0 mM) inhibited GAPDH by 25 to 30#, and at 
enzyme saturation levels of both substrates these adenine 
nucleotides (1.0 mM) inhibit GAPDH by approximately 10^. At 
higher concentrations of substrates the inhibition is even 
further relieved indicating that the adenine nucleotides are 
not noncompetitive inhibitors. Inhibition of GAPDH by 
adenine nucleotides has been shown for rabbit muscle (19,
^5), rabbit heart (^5), and yeast (^5, 51, 6^). This type 
of inhibition has been characterized for several sources as 
mixed inhibition in rabbit tissues (45) and competitive in 
yeast (45, 51, 64). For rabbit tissues (46) the degree of 
phosphorylation does not affect the degree of inhibition by 
the adenine nucleotides; whereas, for yeast GAPDH (64) 
cyclic AMP is a very potent inhibitor (yo# at 1 mM), while 
AMP, ADP, and ATP inhibit by 18 , l4, and 10^, respectively. 
Deal and co-workers hypothesize that for yeast GAPDH the two 
nucleotide moieties of NAD"’ have almost totally independent 
functions, the adenine nucleotide moiety is responsible for 
binding and the nicotinamide nucleotide moiety for catalysis. 
They found that a series of adenine containing compounds 
produced three distinct but related effects on yeast GAPDH 
activity and structure. They are (1 ) instantaneous inhibi­
tion of enzyme activity by AMP, ADP, ATP, and cyclic AMP 
due to competition with NAD'*’ for the NAD'*’ binding site on 
the enzyme (64); (2 ) a slow loss of enzymic activity pro­
duced by AMP, ADP, and ATP due to a slow, marked structural
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change (̂ 1, 64); and (3 ) a very rapid loss of activity pro­
duced hy ADP and ATP in the presence of chymotrypsin due to 
an induced structural change (64). Comparison of the GAPDH 
from human embryonic lung tissue with yeast and rabbit GAPDH 
indicates that even though each enzyme possesses individual 
characteristics, they have many common properties. For 
example, the initial affect of adenylates is the same for 
all three sources.
For GPDH from WI-38 and WI -38 VAI3A, the pH profiles 
were identical with a pH optimum at 8.0. Examination of 
Table 4 indicates that at a concentration of G-6-P less than 
0 .0 8 mM, the interaction coefficients are nearly one for both 
cell types; and at a G-6-P concentration greater than O.O8 mM, 
the interaction coefficients are about two. The same type of 
change is also observed for NADP^ for both cell types. These 
results were found when it was observed that the Hill plots 
could be drawn with two slopes for G-6-P and NADP^ for WI-38 
and WI-38 VAI3A. The implication is that at a G-6-P con­
centration less than O.O8 mM and at a NADP* concentration 
less than 0.10 mM very little, if any, interaction of the 
substrate binding sites occur, and at substrate concentra­
tions greater than these, interaction of the substrate 
binding sites does occur, or that two GPDH isozymes exist 
one of which has interacting binding sites for G-6-P and 
NADP'*’. From Table 6 it is evident that the affinity of GPDH 
is dependent on the concentration of G-6-P while the
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affinity for NADP"*" does not seem to be dependent on NADP^ 
concentration regardless of the kind of cell. Also, examina­
tion of Figures 5 and 7 indicates that the G-6-P saturation 
curves are not hyperbolic but possess an intermediate 
plateau. The corresponding Lineweaver-Burk plots (Figures 
6 and 8 ) indicate that in order to obtain a straight line the 
reciprocal values for the concentrations of G-6-P may be 
plotted directly below 0.08 mM and must be squared above 
0.08 mM. A composite picture of these results is that below 
a G-6-P concentration of 0.08 mM the concentration of sub­
strate to give half maximum velocity (S)q ^ for G-6-P is 
about 0.01 mM, and the interaction coefficient is approxi­
mately one. Above a G-6-P concentration of 0.08 mM the
(S)„ r- for G-6-P is 0.0^0 mM and the interaction coef- 0.5
ficient is nearly 2.0. Before reaching a G-6-P concentra­
tion of 0.08 mM the GPDH activity appears to be very nearly 
saturated; however, at a G-6-P concentration of 0.08 mM the 
GPDH activity increases and finally becomes constant at 
0.15 mM G-6-P. The binding of HADP"̂  seems to be analogous 
to the G-6-P binding. The NADP"̂  binding sites appear to in­
teract but the affinity for NADP'*' is not significantly 
changed. To explain these results, two possibilities exist: 
(1) two isozymes, one of which has interacting G-6-P binding 
sites, or (2 ) one enzyme that exhibits negative co- 
operativity. Examination of the dashed lines in Figures 5 
and 7 show how the experimental data can be extended to
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simulate two overlapping saturation curves. These data also 
fit the criteria of Koshland and co-workers for negative 
co-operativity (5 3)? i.e. (1) the enzyme must possess a total 
of more than two substrate binding sites and (2 ) the relative 
magnitude of the intrinsic catalytic or binding constants 
of these sites first decreases, then increases as the 
enzyme is saturated which results in an intermediate plateau 
region in the enzyme saturation curve. From considering the 
initial velocity equation for a two-site model enzyme, they 
also concluded that, "neither a single enzyme with two sub­
strate binding sites nor a mixture of enzymes, each with one 
substrate binding site, in the presence or absence of ef­
fectors, will yield curves possessing an intermediate 
plateau region, provided that both the rate of binding is 
rapid relative to the rate of catalysis (53)*" Seemingly, 
a discrepancy exists between the GPDH data and Koshland*s 
criteria, i.e.-the Hill plots for GPDH indicate the oc­
currence of two interacting sites. But, by dialysis of the 
GPDH containing solution it was found that GPDH has sig­
nificantly high endogenous activity for both substrates.
The implication is that at least one G-6-P and NADP^ moiety 
are tightly bound to the enzyme. Thus, the Hill plots 
probably show only two weaker binding sites, and Koshland*s 
criteria for the existence of more than two binding sites is 
satisfied. Luzzatto (41 ) has reported that the NADP’*' satur­
ation curve of GPDH from human erythrocytes is sigmoidal.
92
the interaction coefficient is about I.7 , and a transition 
from low (Kg= 0.0^5 mM) to high (Kg= 0.013 mM) affinity for 
NADP^ is found. Recent work (6) has shown that two GPDH 
isozymes exist in WI-38 and 8V4-0 transformed WI-3 8 ; thus, 
the isozyme theory may explain the cause of the intermediate 
plateau in the G-6-P saturation curve. However, purifica­
tion and kinetic analysis of GPDH from these cells is neces­
sary in order to prove the isozyme explanation. Comparison 
of this work to that on human erythrocytes (4-1 ) indicates a 
difference in the NADP"̂  saturation for both sources even 
though Luzzatto's Kg at high concentration of NADP"̂  agrees 
quite well with this work.
From Table 7, it is evident that only inorganic 
phosphate (1.0 mM) inhibited GPDH. This inhibition was ap­
proximately 30^ in both cell types at enzyme saturating 
levels of NADP"̂  and G-6-P. The physiological significance 
of this inhibition is not clear.
The final enzyme to be discussed is PK. Since PK 
did not show any statistical variation from both cell sources 
it was not surprising that the substrate K^'s as well as the 
pH profiles were identical. The pH profile is the sharpest 
of the four enzymes examined with the pH optimum range 7.0 
to 7«5* From Table 4-, it is evident that the interaction 
coefficient for PEP and ADP in both sources is nearly 2.0.
The implication is that there are at least two interacting 
binding sites for ADP and PEP in both types of cells. For
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¥1-38 and ¥1-38 VA13A the for ADP was roughly O.3O to 
O.'+O mM which compares closely with the Kjjj from rabbit 
muscle, 0 .3 0 mM, (8 ) and human red blood cells, 0.33 mM, 
(3 0 ). The for PEP for the human embryonic lung cells, 
0.26 mM, compares favorably with that for rat liver PK,
0.10 to 0 .3 0 mM, (5, 60).
Of the enzymes studied PK proved to be regulated to 
the greatest extent. PK from both sources was activated by 
potassium ions (K^), (see Figure 26) and FDP, (see Figure 
20). Also, PK from both sources was inhibited by L- 
alanine and ATP, (see Figures 15-19 and 21-25). For K^ 
activation (10 fold) it was found that the enzyme from 
either source was saturated at a concentration of 50 mM KOI 
and that the enzyme was one-half saturated at 10 mM KOI. 
Also, it was found that at enzyme saturating levels of
INHL). a 2 fold activation was observed and for Na no effect 
was observed, respectively. The effect of K’*’ ions has been 
documented for PK from other sources: erythrocyte PK was
activated by K"̂  and (3 0 ), rat liver PK requires a
monovalent cation K"*" or with more efficient than
K (12), yeast PK is strongly activated by K and with
having about one-half the activating potential of K"*" 
(28); and both rabbit muscle and Ehrlich ascites-tumor 
cells have an absolute requirement for a monovalent ion 
either K""" of is equally effective (11). The K"̂  re­
quirement or K'*' activation of PK is possibly related to the
9^
electrolyte pump mechanism of cells. That is, in order to 
maintain a high intercellular level of K'*’ an ATP dependent 
ion translocation mechanism is used by the cell. Thus, the 
activation of PK would result in greater regeneration of 
ATP and would help maintain the ATP level necessary to main­
tain a proper intracellular K^ level. The other activator 
of PK activity, FDP, in both cells seems to be a common 
activator of regulated PK's from a variety of sources, e.g. 
rat liver (5? 38, 59? 61), yeast (25), E. coli (42), mouse 
liver (3 8). Weber and co-workers have done extensive work 
on the regulation of PK from rat liver (59, 61). They found 
a 1 .9 fold stimulation by FDP which appeared as a mixed 
activator with respect to PEP (59)* By comparison, for the 
human embryonic lung cells the stimulation by FDP was 2 fold 
and FDP (1.0 mM) appears to be a noncompetitive activator 
with respect to PEP (see Figure 20). As shown in Figure 27, 
the FDP activation of PK is greatly reduced by storage.
This sensitivity implies that the FDP binding site is a very 
sensitive allosteric binding site. Weber et al. also found 
that ATP inhibition was 37^ and mixed with respect to 
enzyme saturating levels of ADP and 61^ and noncompetitive 
with respect to enzyme saturating levels of PEP (59). For 
PK described in this dissertation ATP was a noncompetitive 
inhibitor: with respect to both substrates and the degree 
of ihhibiifion was approximately 50^ at 1 mM ATP. For rat 
liver Weber and co-workers found that L-alanine was a
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competitive inhibitor (6l)• However, it was found in this 
study that L-alanine was non-competitive with respect to both 
substrates and the degree of inhibition by L-alanine (1 mM) 
was approximately 50 .̂
The physiological significance of FDP activation, 
L-alanine inhibition, and ATP inhibition is more obvious 
than for K'*' activation. From a glycolytic standpoint the 
significance of FDP stimulation of PK is evident, i.e. it 
is a forward feed to improve the efficiency of glycolysis. 
However, as was pointed out by Weber (59) under conditions of 
gluconeogenesis this is an undesirable property. He sug­
gested that inhibition of PK by free fatty acids, which are 
more prevalent under gluconeogenic conditions, offsets FDP 
activation of PK, and thus, permits FDP to be utilized in 
gluconeogenesis. Even though ATP and L-alanine were not 
shown to antagonize FDP activation of human embryonic lung 
PK, it is probable that the existence of intracellular 
levels of ATP and L-alanine higher than normally tolerated 
could result in preferential utilization of FDP in gluco­
neogenesis. Of course, it is reasonable to assume that when 
intracellular conditions are suitable for gluconeogenesis 
the intracellular levels of ATP and L-alanine would be 
maximal and more likely to be inhibitory levels. From a 
glycolytic standpoint ATP and L-alanine appear to be classic 
feedback inhibitors (2). The inhibition of PK by ATP fits 
in quite well with Atkinson's adenylate control hypothesis
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for glycolysis (3) (AMP stimulates the unique glycolytic 
enzyme of hexose phosphate utilization and ATP inhibits the 
unique glycolytic enzyme of triose phosphate utilization). 
The end result being adenylate modulation of the unique 
enzymes of glycolysis and of ATP production by glycolysis 
and respiration. The inhibition of PK by L-alanine can also 
be interpreted as end product control of its own biosyn­
thesis. Thus, the net result of L-alanine and ATP inhibi­
tion of PK is inhibition of glycolysis and creation of 
conditions suitable for gluconeogenesis.
CHAPTER VI 
SUMMARY
Results, conclusions, and speculations concerning 
the biochemical differences and similarities with respect to 
glycolysis and glycolytic regulation were studied using the 
human diploid cell line WI-38 and its 8V40 transformed 
counterpart WI -38 VAI3A. In particular it was found that 
under the described culturing conditions that WI-38 has ap­
proximately a 2 . 5  fold greater rate of lactate production 
and glucose utilization. The adenine nucleotide levels were 
found to be significantly different. Speculations are of­
fered to explain these differences. The specific activities 
of the glycolytic enzymes with the exception of enolase and 
phosphoglyceromutase were measured. Also, the levels of 
GPDH and 6PGADH of the hexose monophosphate shunt were de­
termined. The specific activities of HK, FDPase, GAPDH, 
GPDH, and 6PGADH measured for both cell types were found to 
be statistically different. The implications of these re­




Of the enzymes that were shown to have specific ac­
tivities that were statistically different between both 
cells, only FDPase was not studied. FDPase was not studied 
because of its very low activity in the cell free prepara­
tion. In order to determine any kinetic similarities or 
differences pH profiles and saturation curves were made for 
these enzymes in both cell sources. From the data collected 
for the saturation curves, Hill plots and Lineweaver-Burk 
plots were made. In addition to determining kinetic pa­
rameters of these enzymes a comprehensive study was under­
taken to compare their regulation by small molecular weight 
metabolites. Speculation is offered on whether the dif­
ference in the enzyme profiles is due to an increase in the 
biosynthesis of the affected enzymes or biosynthesis of an 
isozyme which has a specific activity that could produce the 
observed increase or decrease in specific activity. It was 
concluded that at least under our cultivation conditions a 
correlation of increased glycolysis to neoplastic transfor­
mation cannot be made for the WI-38 and WI -38 VAI3A set as 
can be made for Rous sarcoma or polyoma viral transformed 
cells.
Examination of PK indicated that it is highly regu­
lated in both types of cells. The physiological significance 
of this regulation by adenosine triphosphate, L-alanine, and 
fructose diphosphate was discussed in relation to glycolysis 
and gluconeogenesis.
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The G-6-P saturation curve of GPDH was found to have 
an intermediate plateau region. The significance and cause 
of such a region were discussed.
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